Multiple Sclerosis

Type: Keyphrase
Name: Multiple Sclerosis
First reported 1 hour ago - Updated 32 mins ago - 2 reports

Biogen Idec First Quarter 2014 Revenues Reach $2.1 Billion Driven By Continued Strength Of MS Franchise

Biogen Idec Inc. (NASDAQ: BIIB) today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013. The revenue growth year-over-year was driven by strong TECFIDERA performance and from recording ... [Published TheStreet.com - 54 mins ago]
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Woman with MS denied the medicines she needs to walk

A young woman with Multiple Sclerosis has been denied access to a medicine that greatly improves her condition.Catriona O’Donnell, who’s 33, was diagnosed with MS ten years ago, after she experienced loss of vision, as well as problems with mobility and ... [Published Derry Journal - 1 hour ago]
First reported 20 hours ago - Updated 3 hours ago - 3 reports

Multiple sclerosis: a review of current treatments for physicians

A review of the literature on treating multiple sclerosis (MS) aims to provide physicians with evidence-based information on the latest treatments for this chronic disease. ... [Published MS News - 3 hours ago]
Entities: Multiple Sclerosis
First reported 6 hours ago - Updated 6 hours ago - 1 reports

UQ turns red for a reason

The University of Queensland will again be bathed in red for the month of May to raise awareness of multiple sclerosis.UQ will switch on red floodlights on the northern side of the Forgan Smith building between dusk and midnight throughout MS Awareness ... [Published University of Queensland - 6 hours ago]
First reported 14 hours ago - Updated 11 hours ago - 3 reports

Walk MS set for April 27 in Lake Como

Little Silver resident Barbara Sager has been named the 2014 Walk Multiple Sclerosis (MS) Ambassador for the New Jersey Metro Chapter’s Walk MS event on Sunday, April 27, at Bar A in Lake Como.Proceeds from the walk will raise funds for programs and services ... [Published Hub - 11 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Drug therapy for multiple sclerosis

,doi: 10.1503/cmaj.130727 Original ArticlesThe first page of the PDF of this article appears below. ... [Published Canadian Medical Association Journal - 11 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Summer Comfort program offers free air conditioners to those with multiple sclerosis

As it has done since 1998, the Multiple Sclerosis Society of Portland will distribute free air conditioning units to MS patients through its Summer Comfort program.This year, a $5,000 grant from Nike via the Oregon Community Fund will allow the nonprofit ... [Published Oregonian - 12 hours ago]
First reported Apr 22 2014 - Updated 12 hours ago - 5 reports

Data from Genzyme’s Multiple Sclerosis Franchise Featured at AAN

Data from Genzyme’s Multiple Sclerosis Franchise Featured at AAN ... [Published Noodls - 12 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 2 reports

Comment on 'Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis' by Stefan Kipfer and David W Crook

First reported 23 hours ago - Updated 23 hours ago - 1 reports

Supporting work for people with multiple sclerosis

People with multiple sclerosis experience some of the highest rates of unemployment among groups of individuals with severe and chronic disabilities. While unpredictable relapses, physical and cognitive symptoms all may play a role in job loss, it is ... [Published Multiple Sclerosis Journal current issue - 23 hours ago]
First reported Apr 21 2014 - Updated Apr 22 2014 - 2 reports

Sun 4/27: UPCOMING: Walk MS 2014

9 a.m. April 27, Esther Short Park, West Eighth Street and Columbia Way. Charitable walk raises money for multiple sclerosis research and support. Volunteers requested. * http://walkorc.nationalmssociety.org/site/TR/Walk/ORCWalkEvents?fr_id=23374&pg=entry ... [Published Columbian.com - Apr 22 2014]
Entities: Multiple Sclerosis
First reported Apr 21 2014 - Updated Apr 21 2014 - 2 reports

MS Walk Kicks Off $40K Drive

Please login to view the requested resource.Participants begin Saturday’s annual Walk MS event at the JMU Festival Conference And Student Center in Harrisonburg. The event raises money to support programs and research for people living with multiple sclerosis. ... [Published Daily News-Record - Apr 21 2014]

Quotes

...MS patients in Europe and ALPROLIX for hemophilia B patients in the United States and Canada," said Chief Executive Officer George A Scangos, Ph D "Following an excellent first year of sales in the U S , TECFIDERA is off to a solid start in Germany, with plans to launch in additional countries in the coming months. Through the remainder of 2014 we anticipate regulatory decisions on new products for hemophilia and MS, and several important early-stage proof-of-concept and clinical study read-outs - and through our collaboration with Eisai we are building one of the broadest research portfolios targeting Alzheimer's disease."
"Do the other high efficacy agents have the same effect on vaccination? Fingolimod blunts your recall and novel immune response to component vaccines. Live vaccines are contra-indicated if you are on fingolimod. With alemtuzumab vaccinations are contra-indicated until 3 months after the last course of treatment and your blood counts have recovered enough to mount an immune response. Some preliminary data (abstract below) suggests that immune responses to both component and live vaccines post-alemtuzumab are intact. This is not surprising as once your immune system recovers post-alemtuzumab it is capable of mounting an immune response. Confirmatory data on vaccination post-alemtuzumab is required as the study below is very small."
"These new analyses provide further evidence of how Gilenya impacts four key measures of MS disease activity. Additionally, new data reinforcing Gilenya's positive effect on brain volume loss are of significant interest to the MS community. People with MS lose brain volume up to three to five times faster than people without MS and these data will highlight the importance of a treatment that can minimize brain volume loss in patients" said David Epstein, Division Head, Novartis Pharmaceuticals
"We're presenting authors whose writing pushes boundaries, challenging and provoking audiences to question their own concepts of culture, history and identity."

More Content

All (4009) | News (2784) | Reports (1) | Blogs (1154) | Audio/Video (0) | Fact Sheets (18) | Press Releases (43)
sort by: Date | Relevance
Biogen Idec First Quarter 2014 Revenues Reach $... [Published TheStreet.com - 54 mins ago]
Biogen Idec First Quarter 2014 Revenues Reach $... [Published Nasdaq - 1 hour ago]
How to Make Doctors Irrelevant [Published Yahoo! UK and Ireland - 1 hour ago]
Woman with MS denied the medicines she needs to... [Published Derry Journal - 1 hour ago]
Half and Half Appeal: Calculating the cost of care [Published Yorkshire Evening Post - 1 hour ago]
Multiple sclerosis: a review of current treatme... [Published MS News - 3 hours ago]
Clinic speak: highly-effective DMTs and immuniz... [Published Multiple Sclerosis Research - 5 hours ago]
Anything but dumb [Published The Nation Pakistan - 5 hours ago]
Forceps damage causing fatigue and depression [Published Multiple Sclerosis Research - 6 hours ago]
Novartis Reports Data From FREEDOMS And FREEDOM... [Published FinanzNachrichten.de - 6 hours ago]
UQ turns red for a reason [Published University of Queensland - 6 hours ago]
North Las Vegas examines regulating medical mar... [Published Las Vegas Review Journal - 7 hours ago]
Michiganians can't afford deep Medicare cuts [Published Detroit News - 7 hours ago]
Obituaries April 23, 2014 [Published High Point Enterprise - 7 hours ago]
Top talent is heading west for writers' festival [Published Penrith Star - 7 hours ago]
In Celebration of Bees [Published Ecology Global Network - 7 hours ago]
PREMIER BIOMEDICAL : CEO to Participate in Brew... [Published 4 Traders - 7 hours ago]
It's official: Gilead's Sovaldi zooms past prev... [Published FiercePharma - 7 hours ago]
End Of Debate: Let Marijuana Remain Illegal [Published Modern Ghana - 7 hours ago]
Cytokine receptor peptides, compositions thereo... [Published Free Patents Online - 9 hours ago]
Napkin notes at Md. coffee shop helping connect... [Published FOX WTTG Washington - 9 hours ago]
New: Medical marijuana advocates show new suppo... [Published Northland's NewsCenter - 9 hours ago]
Positing Parkinson's as an autoimmune disease [Published Drug Discovery News - 10 hours ago]
Progress shown in brain disorder [Published U-T San Diego - 10 hours ago]
Low testosterone is associated with disability ... [Published UroToday - 11 hours ago]
Doctors and patients disappointed new MS drug h... [Published Florida Times-Union - 11 hours ago]
Big Country calendar for April 23-26, 2014 [Published Abilene Reporter - 11 hours ago]
Walk MS set for April 27 in Lake Como [Published Hub - 11 hours ago]
Drug therapy for multiple sclerosis [Published Canadian Medical Association Journal - 11 hours ago]
NQO1 gene rs1800566 variant is not associated w... [Published BMC - 11 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Multiple sclerosis: a review of current treatme... [Published MS News - 3 hours ago]
A review of the literature on treating multiple sclerosis (MS) aims to provide physicians with evidence-based information on the latest treatments for this chronic disease. ...
Clinic speak: highly-effective DMTs and immuniz... [Published Multiple Sclerosis Research - 5 hours ago]
Vaccinations on highly-effective DMTs; what you need to know. #ClinicSpeak #MSBlog #MSResearch "This study below shows that MSers treated with natalizumab mount an immune response to both a memory, or recall, vaccine (tetanus) and a new vaccine challenge ...
Forceps damage causing fatigue and depression [Published Multiple Sclerosis Research - 6 hours ago]
Gobbi C, Rocca M, Pagani E, Riccitelli G, Pravatà E, Radaelli M, Martinelli-Boneschi F, Falini A, Copetti M, Comi G, Filippi M. Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.  Mult Scler. 2014 Apr. [Epub ahead ...
In Celebration of Bees [Published Ecology Global Network - 7 hours ago]
A Bumblebee makes his approach for a landing on a Wisteria flower. Photo Doug Wertman/flickr It’s spring and with flowers blooming and birds singing, it’s a perfect time to celebrate the little insects that makes the biggest impact on our world…Bees! ...
#HealthTalk: Living Well With MS — Hosted by Dr... [Published MS News - 16 hours ago]
*It’s time for another Twitter chat about living with MS. Drs. Sanjay Gupta and Robert Fox join us this time* Tomorrow – Wednesday, April 23rd  at 1 pm ET – Everyday Health will be hosting another Twitter chat about living with MS. “Living Well With ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Data from Genzyme’s Multiple Sclerosis Franchis... [Published Genzyme Press Release - Apr 22 2014]
Sanofi: Genzyme to Resubmit Lemtrada Applicatio... [Published GlobeNewswire: Acquisitions News - Apr 07 2014]
Genzyme to Resubmit LemtradaTM Application for ... [Published Genzyme Press Release - Apr 07 2014]
Change in the clinical development program for ... [Published GlobeNewswire: Acquisitions News - Feb 19 2014]
Change in the clinical development program for ... [Published GlobeNewswire: Acquisitions News - Feb 19 2014]
1 2 3 4 5 6 7 8 9
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.